investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

A Randomized Trial of Tac/MTX/bortezomib vs Tac/MTXplacebo in Allogeneic HSCT

Joseph H Antin

0 Collaborator(s)

Funding source

National Institutes of Health (NIH)

Related projects

James K Chen

Chemical genetic dissection of Hipk4-dependent Hedgehog pathway activation

Leukaemia

Scott Moore Carlson

The role of PRDM1 in epigenetic regulation and tumor suppression

Hodgkin lymphoma Leukaemia Non-Hodgkin lymphoma

Tracy L Mcgaha

The role of marginal zone macrophages and immuno-metabolism in tumor-driven MDSC development

Non-Hodgkin lymphoma Hodgkin lymphoma

Pathology Hematology and hematologic malignancies

Ann Moorman

T Cell Immunity in Endemic Burkitt Lymphoma

Non-Hodgkin lymphoma

Pediatric oncology or childhood cancer

Kristen Elizabeth Norman Scott

c-MYC dependent regulation of de novo lipogenesis in B-cell lymphomagenesis

Non-Hodgkin lymphoma Hodgkin lymphoma

Gerd P Pfeifer

5-hydroxymethylcytosine in Human Cancer

Leukaemia

David FitzGerald

Bio-Therapies for the Treatment of Cancer

Leukaemia

Hao Yuan Kueh

Single cell analysis of hematopoietic cell fate determination

Leukaemia

George Thomas

The Function of rpL5 and rpL11 in Induction of p53

Non-Hodgkin lymphoma

Hematology and hematologic malignancies Pathology

Sign Up For Updates

Stay up to date with what's going on with The GO Map.